Article Name Predictive Diagnostics
Bangkok Dusit Medical Services Partners with CNN to Tackle Global Health Challenges
Collaboration aims to explore next-gen healthcare solutions through innovation and global insights.
11th February, 2025
NUS Scientists develop advanced 'Micro-Gut' Model to study Gut Microbes and Human Diseases
Breakthrough innovation enables realistic simulation of gut environments for deeper insights into microbiome-related health conditions.
11th February, 2025
The Growing Trend of Social Egg and Embryo Freezing: Empowering Women to Plan Parenthood on Their Own Terms
Dr. Kaushal Kadam, MBBS, MD, DGO and Director, Corion Fertility Clinic Pvt Ltd.
10th February, 2025
“There remains a high unmet need for new & alternative treatment options for prurigo nodularis & atopic dermatitis”
Asia-Pacific region houses some of Galderma’s fastest growing markets, where sales have fueled a strong performance. There have been multiple successes in the region in 2024 for the Swiss pharmaceutical firm, with a number of important product launches, such as Restylane VOLYME in China, Restylane EYELIGHT in Korea and Alastin in Australia. More recently, Relfydess (RelabotulinumtoxinA) was approved in Australia and Sculptra - which celebrated its 25th launch anniversary this year - was approved in China. Gerry Muhle, Galderma’s Head of Global Product Strategy, spoke to BioSpectrum Asia in detail about the company’s growth plans in 2025 and beyond.
03rd February, 2025
Madhya Pradesh Chief Minister Showcases Ujjain’s Medical Device & Pharma Park to Japanese Investors in Tokyo, Positioning MP Among India’s Leading Industrial States
Dr. Mohan Yadav discusses strategic investment opportunities with A&D Medical, highlighting Madhya Pradesh’s business-friendly policies, infrastructure incentives, and vision for advancing life sciences manufacturing in India.
29th January, 2025
Scorpius Holdings Announces Collaboration with KaloCyte to Advance Manufacturing for ErythroMer™
Partnership highlights Scorpius’ expertise in supporting innovative therapeutic programs
24th January, 2025
Micron Biomedical raises $33M+ to advance Needle-Free Therapeutics and Vaccines
Series A funding boosts efforts to commercialize innovative healthcare solutions.
17th January, 2025
CMU Healthcare and Nobel Laureate Randy Schekman pioneer advances in Exosome Technology
Collaboration explores groundbreaking applications in cellular communication and therapy.
16th January, 2025
UCSF and GE HealthCare Launch Care Innovation Hub to Tackle Cancer and Neurodegenerative Diseases with Advanced Imaging Solutions
New joint research initiative combines UCSF’s clinical and research expertise with GE HealthCare’s engineering innovation to improve diagnosis, enhance access to precision treatments, and drive breakthroughs in brain health, oncology, and imaging technology.
16th January, 2025
QIAGEN enhances QIAcuity Digital PCR with Advanced Multiplexing
New capabilities provide deeper insights from biological sample analysis.
13th January, 2025
Quanterix to acquire Akoya Biosciences, pioneering integrated biomarker detection
Merger combines ultra-sensitive blood and tissue protein analysis into a unified platform.
13th January, 2025
Persistent Systems launches Pi-OmniKG to transform biomedical research with GenAI and Google Cloud
Empowering healthcare and life sciences with faster insights, streamlined data mining, and AI-driven innovation.
10th January, 2025
Alamar Biosciences establishes commercial presence in Asia Pacific region
With first ARGO HT installation at Hong Kong Center for Neurodegenerative Diseases
08th December, 2024
Indian company SunAct inks deal with Malaysian firm Abgentil to introduce cutting-edge cancer treatment for solid state tumours in India
To introduce CAR-T, TCR and TIL therapies for solid state tumours in India
27th November, 2024
Beurer India introduces GL 22 blood glucose monitor
Combining German precision with advanced technology designed to meet local needs
25th November, 2024
Celularity expands advanced biomaterial product commercial portfolio with acquisition of rebound™ product from Sequence LifeScience, Inc.
Placental-Derived Allograft Matrix 'Rebound' from Sequence LifeScience
17th October, 2024
City Imaging & Clinical Labs to expand services to 50 hospitals in North India by March 2027
Plans to offer hospital lab management services to over 50-bedded hospitals
15th October, 2024
Inspira announces development of new disposable kit with built-in performance monitoring mechanism
To enhance product safety and improve patient protection
09th October, 2024
Medtech Special
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer